A detailed history of Trustcore Financial Services, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Trustcore Financial Services, LLC holds 42 shares of MYGN stock, worth $281. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Previous 42 -0.0%
Holding current value
$281
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021

SELL
$12.16 - $19.77 $2,432 - $3,954
-200 Reduced 82.64%
42 $1,000
Q4 2019

Jan 30, 2020

BUY
$20.93 - $35.1 $4,374 - $7,335
209 Added 633.33%
242 $7,000
Q3 2019

Oct 30, 2019

BUY
$22.08 - $47.08 $728 - $1,553
33 New
33 $1,000
Q1 2018

May 04, 2018

SELL
$28.83 - $41.01 $2,883 - $4,101
-100 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$28.45 - $37.14 $2,845 - $3,714
100
100 $3,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $541M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.